Ex vivo Sensitivity Profile of Plasmodium falciparum Clinical Isolates to a Panel of Antimalarial Drugs in Ghana 13 Years After National Policy Change

References

• World Health Organization.World Malaria Report 2020: 20 Years of Global Progress and Challenges. World Health Organisation; 2020 https://www.who.int/publications/i/item/9789240015791.
   Google Scholar
• Müller O. Malaria in Africa: Challenges for Control and Elimination in the 21st Century. Peter Lang Frankfurt; 2011.
   Google Scholar
• Hyde JE. Drug-resistant malaria. Trends Parasitol. 2005;21(11):494–498. doi:10.1016/j.pt.2005.08.02016140578
   PubMed Web of Science ®Google Scholar
• Sibley CH. Understanding drug resistance in malaria parasites: basic science for public health. Mol Biochem Parasitol. 2014;195(2):107–114. doi:10.1016/j.molbiopara.2014.06.00124927641
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum Malaria. N Engl J Med. 2009;361(5):455–467. doi:10.1056/NEJMoa080885919641202
   PubMed Web of Science ®Google Scholar
• WHO. Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000-2010. 2010.
   Google Scholar
• Goldberg DE, Siliciano RF, Jacobs WR. Outwitting evolution: fighting drug-resistant TB, Malaria, and HIV. Cell. 2012;148(6):1271–1283. doi:10.1016/j.cell.2012.02.02122424234
   PubMed Web of Science ®Google Scholar
• Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359(24):2619–2620. doi:10.1056/nejmc080501119064625
   PubMed Web of Science ®Google Scholar
• Phyo AP, Nkhoma S, Stepniewska K, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379(9830):1960–1966. doi:10.1016/S0140-6736(12)60484-X22484134
   PubMed Web of Science ®Google Scholar
• Na-Bangchang K, Ruengweerayut R, Mahamad P, Ruengweerayut K, Chaijaroenkul W. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border. Malar J. 2010;9(1):1–10. doi:10.1186/1475-2875-9-27320043863
   PubMed Web of Science ®Google Scholar
• Beshir K, Sutherland CJ, Merinopoulos I, et al. Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76. Antimicrob Agents Chemother. 2010;54(9):3714–3716. doi:10.1128/AAC.00358-1020547800
   PubMed Web of Science ®Google Scholar
• Sa JM, Twu O. Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type. Malar J. 2010;9(1):374. doi:10.1186/1475-2875-9-37421182787
   PubMed Web of Science ®Google Scholar
• Folarin OA, Bustamante C, Gbotosho GO, et al. In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Trop. 2011;120(3):224–230. doi:10.1016/j.actatropica.2011.08.01321920347
   PubMed Web of Science ®Google Scholar
• Rogers WO, Sem R, Tero T, et al. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J. 2009;8(1):1–9. doi:10.1186/1475-2875-8-1019118502
   PubMed Web of Science ®Google Scholar
• Wongsrichanalai C, Meshnick SR. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis. 2008;14(5):716–719. doi:10.3201/eid1405.07160118439351
   PubMed Web of Science ®Google Scholar
• Witkowski B, Iriart X, Soh PN, et al. pfmdr1 amplification associated with clinical resistance to mefloquine in West Africa: implications for efficacy of artemisinin combination therapies. J Clin Microbiol. 2010;48(10):3797–3799. doi:10.1128/JCM.01057-1020668121
   PubMed Web of Science ®Google Scholar
• Ashley EA, Dhorda M, Fairhurst RM, et al. Spread of artemisinin resistance in Plasmodium falciparum Malaria. N Engl J Med. 2014;371(5):411–423. doi:10.1056/nejmoa131498125075834
   PubMed Web of Science ®Google Scholar
• Mita T, Tanabe K, Kita K. Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int. 2009;58(3):201–209. doi:10.1016/j.parint.2009.04.00419393762
   PubMed Web of Science ®Google Scholar
• Petersen I, Eastman R, Lanzer M. Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 2011;585(11):1551–1562. doi:10.1016/j.febslet.2011.04.04221530510
   PubMed Web of Science ®Google Scholar
• Koram K, Quaye L, Abuaku B. Efficacy of amodiaquine/artesunate combination therapy for uncomplicated malaria in children under five years in ghana. Ghana Med J. 2008;42(2):55–60.19180204
   PubMedGoogle Scholar
• Adjei GO, Kurtzhals JAL, Rodrigues OP, et al. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malar J. 2008;7:127–137. doi:10.1186/1475-2875-7-12718620577
   PubMed Web of Science ®Google Scholar
• Quashie NB, Duah NO, Abuaku B, et al. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs. Malar J. 2013;12(1):1–12. doi:10.1186/1475-2875-12-45023282136
   PubMed Web of Science ®Google Scholar
• Färnert A, Williams TN, Mwangi TW, et al. Transmission‐dependent tolerance to multiclonal Plasmodium falciparum Infection. J Infect Dis. 2009;200(7):1166–1175. doi:10.1086/60565219702508
   PubMed Web of Science ®Google Scholar
• Abuaku BK, Mensah BA, Ofori MF, et al. Efficacy of artesunate/amodiaquine in the treatment of uncomplicated malaria among children in Ghana. Am J Trop Med Hyg. 2017;97(3):690–695. doi:10.4269/ajtmh.15-082628749762
   PubMed Web of Science ®Google Scholar
• Ghana Statistical Service. 2010 Population and Housing Census: Summary Report of Final Results.; 2012 Available from: https://www.statsghana.gov.gh/gssmain/storage/img/marqueeupdater/Census2010_Summary_report_of_final_results.pdf. Accessed 116, 2020.
   Google Scholar
• Ministry of Food and Agriculture. Fanteakwa District. Published 2012. Available from: http://mofa.gov.gh/site/sports/district-directorates/eastern-region/225-fanteakwa. Accessed 212 2020.
   Google Scholar
• Abuaku B, Duah N, Quaye L, Quashie N, Koram K. Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana. Malar J. 2012;11(1):388. doi:10.1186/1475-2875-11-38823173737
   PubMed Web of Science ®Google Scholar
• Kweku M, Liu D, Adjuik M, et al. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One. 2008;3(12):12. doi:10.1371/journal.pone.0004000
   Web of Science ®Google Scholar
• Ndiaye D, Patel V, Demas A, et al. Short report: A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials - Increased sensitivity of P. falciparum to chloroquine in senegal. Am J Trop Med Hyg. 2010;82(2):228–230. doi:10.4269/ajtmh.2010.09-047020133997
   PubMed Web of Science ®Google Scholar
• Le Nagard H, Vincent C, Mentré F, And JLB. Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Comput Methods Programs Biomed. 2011;104(1):10–18. doi:10.1016/j.cmpb.2010.08.00320828858
   PubMed Web of Science ®Google Scholar
• Cui L, Mharakurwa S, Ndiaye D, Rathod PK, Rosenthal PJ. Antimalarial drug resistance: literature review and activities and findings of the ICEMR network. Am J Trop Med Hyg. 2015;93:57–68. doi:10.4269/ajtmh.15-0007
   PubMed Web of Science ®Google Scholar
• Ministry of Health. Anti-Malaria Drug Treatment Policy for Ghana: 2nd Revised Version. 2009 Available from: https://www.ghanahealthservice.org/ghs-item-details.php?cid=2&scid=55&id=54. Accessed 116, 2020.
   Google Scholar
• Tinto H, Bonkian LN, Nana LA, et al. Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change. Malar J. 2014;13(1):1–7. doi:10.1186/1475-2875-13-20724383426
   PubMed Web of Science ®Google Scholar
• Fall B, Diawara S, Sow K, et al. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs. Malar J. 2011;10(1):1–8. doi:10.1186/1475-2875-10-31021214892
   PubMed Web of Science ®Google Scholar
• Pascual A, Parola P, Benoit-Vical F, et al. Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum. Malar J. 2012;11(1):45. doi:10.1186/1475-2875-11-4522333675
   PubMed Web of Science ®Google Scholar
• Mbaye A, Gaye A, Dieye B, et al. Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal. Malar J. 2017;16(1):1–7. doi:10.1186/s12936-017-1897-628049519
   PubMed Web of Science ®Google Scholar
• Van Tyne D, Dieye B, Valim C, et al. Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal. Malar J. 2013;12:1. doi:10.1186/1475-2875-12-44123282136
   PubMed Web of Science ®Google Scholar
• Fall B, Pascual A, Sarr FD, et al. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Malar J. 2013;12:1. doi:10.1186/1475-2875-12-10723282136
   PubMed Web of Science ®Google Scholar
• Wurtz N, Fall B, Pascual A, et al. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J. 2012:11. doi:10.1186/1475-2875-11-197.22230255
   PubMed Web of Science ®Google Scholar
• Zatra R, Lekana-douki JB, Lekoulou F, Bisvigou U, Ngoungou EB, Ndouo FST. In vitroantimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon. BMC Infect Dis. 2012;12(1):307. doi:10.1186/1471-2334-12-30723153201
   PubMed Web of Science ®Google Scholar
• Gari-Toussaint M, Pradines B, Médicale VM-LP. 2002 U. Sénégal et paludisme: echec prophylactique vrai de la méfloquine. Presse Med. 2002;31:1136.12162100
   PubMed Web of Science ®Google Scholar
• Duah NO, Wilson MD, Ghansah A, et al. Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria. J Trop Pediatr. 2007;53(1):27–31. doi:10.1093/tropej/fml07617158810
   PubMed Web of Science ®Google Scholar
• Mensah BA, Aydemir O, Myers-Hansen JL, et al. Antimalarial drug resistance profiling of plasmodium falciparum infections in ghana using molecular inversion probes and next-generation sequencing. Antimicrob Agents Chemother. 2020;64(4):e01423–19. doi:10.1128/AAC.01423-1931932374
   PubMed Web of Science ®Google Scholar
• Lu F, Zhang M, Culleton RL, et al. Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China. Parasit Vectors. 2017;10(1):1–9. doi:10.1186/s13071-017-2298-y28049510
   PubMed Web of Science ®Google Scholar
• Fidock D, Nomura T, Talley A. Cell RC-M, 2000 Undefined. Mutations in the P. Falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance. Elsevier; 2021 Available from: https://www.sciencedirect.com/science/article/pii/S1097276505000778. Accessed 14.
   Google Scholar
• Valderramos S, sciences DF-T in pharmacological, 2006 undefined. Transporters involved in resistance to antimalarial drugs. Elsevier. Available from: https://www.sciencedirect.com/science/article/pii/S0165614706002240?casa_token=l5Iq2MBNqxkAAAAA:eVkCC-mAbjafh69cY_SSMJ89xe20_ozWU0WFezUZ_2jl_AOi9UUMSw9UAJbvLyX_ct8DbLsPORw.. Accessed 14 2021.
   Google Scholar
• Oladipo OO, Wellington OA, Sutherland CJ. Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine. Diagn Pathol. 2015;10(1):41. doi:10.1186/s13000-015-0276-225928117
   PubMed Web of Science ®Google Scholar
• Afoakwah R, Boampong JN, Egyir-Yawson A, Nwaefuna EK, Verner ON, Asare KK. High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana. Acta Trop. 2014;136:32–36. doi:10.1016/j.actatropica.2014.03.03024727053
   PubMed Web of Science ®Google Scholar
• Asare KK. Evaluation of Plasmodium falciparum chloroquine resistant markers in selected health facilities in Central Region after seven years of banning chloroquine treatment in Ghana. 2014 https://erl.ucc.edu.gh/jspui/bitstream/123456789/2768/1/ASARE2014.pdf.
   Google Scholar
• Wellems T, Plowe C. Chloroquine-resistant malaria. J Infect Dis. 2001;184:770–776. doi:10.1086/32285811517439
   PubMed Web of Science ®Google Scholar
• Ekland E, Fidock D. In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes. Int J Parasitol. 2008;38:743–747. doi:10.1016/j.ijpara.2008.03.00418406409
   PubMed Web of Science ®Google Scholar
• WHO. World Malaria Report 2019; 2019 https://www.who.int/news-room/fact-sheets/detail/malaria.
   Google Scholar